SEM SELECT MEDICAL HOLDINGS CORP revenue, earnings and financials
For the quarter ended March 31, 2026, SELECT MEDICAL HOLDINGS CORP reported revenue of $1.42B (up 5.0% from a year earlier), net income of $44.0M and diluted EPS of $0.35; over the last four quarters revenue was $5.52B and net income $134M; for the fiscal year ended December 2025 revenue was $5.45B, up 5.1% on the year before.
SEM annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $5.45B, gross profit n/a, operating income $336M, net income $146M (margin 2.7%), EPS $1.16
- Fiscal year ended Dec 2024: revenue $5.19B, gross profit n/a, operating income $268M, net income $214M (margin 4.1%), EPS $1.66
- Fiscal year ended Dec 2023: revenue $4.83B, gross profit n/a, operating income $267M, net income $243M (margin 5.0%), EPS $1.91
- Fiscal year ended Dec 2022: revenue $4.61B, gross profit n/a, operating income $145M, net income $159M (margin 3.4%), EPS $1.23
- Fiscal year ended Dec 2021: revenue $6.20B, gross profit n/a, operating income $714M, net income $402M (margin 6.5%), EPS $2.98
SEM quarterly revenue and earnings
- Quarter ended Mar 31, 2026: revenue $1.42B (up 5.0% year over year), net income $44.0M, EPS $0.35
- Quarter ended Dec 31, 2025 (from the annual report): revenue $1.40B (up 6.4% year over year), net income $20.2M, EPS $0.17
- Quarter ended Sep 30, 2025: revenue $1.36B (up 7.2% year over year), net income $28.8M, EPS $0.23
- Quarter ended Jun 30, 2025: revenue $1.34B (up 4.5% year over year), net income $40.6M, EPS $0.32
- Quarter ended Mar 31, 2025: revenue $1.35B (up 2.4% year over year), net income $56.7M, EPS $0.44
- Quarter ended Dec 31, 2024: revenue $1.31B (up 7.8% year over year), net income −$16.1M, EPS −$0.12
- Quarter ended Sep 30, 2024: revenue $1.27B (up 6.7% year over year), net income $55.6M, EPS $0.43
- Quarter ended Jun 30, 2024: revenue $1.28B (up 6.2% year over year), net income $77.6M, EPS $0.60
- Quarter ended Mar 31, 2024: revenue $1.32B (up 9.3% year over year), net income $96.9M, EPS $0.75
- Quarter ended Dec 31, 2023: revenue $1.22B (up 952.4% year over year), net income $46.3M, EPS $0.36
- Quarter ended Sep 30, 2023: revenue $1.19B (down 24.0% year over year), net income $48.2M, EPS $0.38
- Quarter ended Jun 30, 2023: revenue $1.21B (down 23.8% year over year), net income $78.2M, EPS $0.61
- Quarter ended Mar 31, 2023: revenue $1.21B (down 24.4% year over year), net income $70.8M, EPS $0.56
- Quarter ended Dec 31, 2022 (from the annual report): revenue −$143M (down 109.2% year over year), net income $27.5M, EPS $0.22
- Quarter ended Sep 30, 2022: revenue $1.57B (up 2.2% year over year), net income $27.2M, EPS $0.21
- Quarter ended Jun 30, 2022: revenue $1.58B (up 1.3% year over year), net income $55.2M, EPS $0.43
- Quarter ended Mar 31, 2022: revenue $1.60B (up 3.4% year over year), net income $49.1M, EPS $0.37
- Quarter ended Dec 31, 2021 (from the annual report): revenue $1.56B, net income $49.9M, EPS $0.37
- Quarter ended Sep 30, 2021: revenue $1.53B, net income $76.9M, EPS $0.57
- Quarter ended Jun 30, 2021: revenue $1.56B, net income $165M, EPS $1.22
SEM cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $346M, share buybacks n/a, dividends $0.25 per share
- Fiscal year ended Dec 2024: operating cash flow $518M, share buybacks n/a, dividends $0.50 per share
- Fiscal year ended Dec 2023: operating cash flow $582M, share buybacks n/a, dividends $0.50 per share
- Fiscal year ended Dec 2022: operating cash flow $285M, share buybacks n/a, dividends $0.50 per share
- Fiscal year ended Dec 2021: operating cash flow $401M, share buybacks n/a, dividends $0.38 per share
SEM balance sheet
- Mar 31, 2026: cash $25.7M, total assets $6.04B, total liabilities $3.94B, shareholders' equity $1.76B
- Dec 31, 2025: cash $26.5M, total assets $5.85B, total liabilities $3.82B, shareholders' equity $1.71B
- Sep 30, 2025: cash $60.1M, total assets $5.69B, total liabilities $3.67B, shareholders' equity $1.69B
- Jun 30, 2025: cash $52.3M, total assets $5.74B, total liabilities $3.74B, shareholders' equity $1.67B
- Mar 31, 2025: cash $53.2M, total assets $5.70B, total liabilities $3.65B, shareholders' equity $1.72B
- Dec 31, 2024: cash $59.7M, total assets $5.61B, total liabilities $3.61B, shareholders' equity $1.68B
- Sep 30, 2024: cash $191M, total assets $8.00B, total liabilities $5.70B, shareholders' equity $1.92B
- Jun 30, 2024: cash $111M, total assets $7.88B, total liabilities $6.14B, shareholders' equity $1.42B
What is SEM's revenue?
SELECT MEDICAL HOLDINGS CORP reported $5.52B of revenue over its last four quarters, through March 31, 2026.
Is SEM profitable?
Yes. SELECT MEDICAL HOLDINGS CORP earned $134M over the last four quarters.
What is SEM's EPS?
Diluted earnings per share over the last four quarters were $1.07; $0.35 in the latest quarter.
Does SEM pay a dividend?
SELECT MEDICAL HOLDINGS CORP paid $0.25 per share in dividends in the fiscal year ended December 2025.